GLP-1 RECEPTOR AGONISTS AND COLORECTAL CANCER: BIOLOGICAL PLAUSIBILITY AND CURRENT EVIDENCE. IJITSS 2026, 1 (1(49). https://doi.org/10.31435/ijitss.1(49).2026.4822.